New Report Available: Cellular Tumor Antigen P53 - Pipeline Review, H1 2016
Global Markets Direct's, 'Cellular Tumor Antigen P53 (Tumor Suppressor P53 or Antigen NY-CO-13) - Pipeline Review, H1 2016', provides in depth analysis on Cellular Tumor Antigen P53 (Tumor Suppressor P53 or Antigen NY-CO-13) targeted pipeline therapeutics.
View full press release